The effect of nanoemulsion as a carrier of hydrophilic compound for transdermal delivery

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Tsai, Ming Jun ^a,b   Fu, Yaw Syan ^c   Lin, Yu Hsuan ^c   Huang, Yaw Bin ^c   Wu, Pao Chu ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Cardiology Section   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; DRUG CARRIER; POLIDOCANOL; ROPINIROLE; WATER; ANTIPARKINSON AGENT; EMULSION; INDOLE DERIVATIVE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG MIXTURE; DRUG PENETRATION; DRUG STABILITY; DRUG STORAGE; DRUG TRANSPORT; HUMAN; NANOEMULSION; NONHUMAN; PHYSICAL CHEMISTRY; RAT; RESPONSE SURFACE METHOD; SKIN PERMEABILITY; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; EMULSION; INTRADERMAL DRUG ADMINISTRATION; PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIPARKINSON AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; NANOPARTICLES; PERMEABILITY; RATS;

EID: 84904910896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102850     Document Type: Article

References (37)

1. Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, et al. (2009) Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm 35: 525-547.
2. Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13: 175-187.
3. Kaye CM, Nicholls B (2000) Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet 39: 243-254.
4. Matheson AJ, Spencer CM (2000) Ropinirole: a review of its use in the management of Parkinson's disease. Drugs 60: 115-137. (Pubitemid 30598821)
5. Alonso Canovas A, Luquin Piudo R, Garcia Ruiz-Espiga P, Burguera JA, Campos Arillo V, et al. (2011) Dopaminergic agonists in Parkinson's disease. Neurologia.
6. Tompson DJ, Vearer D (2007) Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Clin Ther 29: 2654-2666.
7. Fuh JL, Lee RC, Wang SJ, Lin CH, Wang PN, et al. (1997) Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg 99: 106-112. (Pubitemid 27279641)
8. Cevc G (2004) Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56: 675-711.
9. Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 30: 1-15. (Pubitemid 24173173)
10. Kim HM, Lim YY, An JH, Kim MN, Kim BJ (2012) Transdermal drug delivery using disk microneedle rollers in a hairless rat model. Int J Dermatol 51: 859-863.
11. Nair A, Vyas H, Shah J, Kumar A (2011) Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv 18: 19-25.
12. Ryan E, Garland MJ, Singh TR, Bambury E, O'Dea J, et al. (2012) Microneedle-mediated transdermal bacteriophage delivery. Eur J Pharm Sci 47: 297-304.
13. Tsai YH, Chang JT, Huang CT, Chang JS, Huang YB, et al. (2012) Electrically-Assisted Skin Delivery of Buspirone Submicron Emulsions. J Food Drug Anal 20: 22-26.
14. Kogan A, Garti N (2006) Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123-126: 369-385. (Pubitemid 44665819)
15. Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, et al. (2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17: 5972-5987.
16. Fang YP, Huang YB, Wu PC, Tsai YH (2009) Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur J Pharm Biopharm 73: 391-398.
17. Shi J, Ma F, Wang X, Wang F, Liao H (2012) Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design. J Liposome Res 22: 270-278.
18. Wang L, Dong J, Chen J, Eastoe J, Li X (2009) Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330: 443-448.
19. El Maghraby GM (2008) Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm 355: 285-292.
20. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A (2003) Microemulsions for topical delivery of estradiol. Int J Pharm 254: 99-107. (Pubitemid 36298819)
21. Mostafa DM, Ammar NM, Abd El-Alim SH, El-anssary AA (2014) Transdermal microemulsions of Glycyrrhiza glabra L.: characterization, stability and evaluation of antioxidant potential. Drug Deliv 21: 130-139.
22. Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA (2013) Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm 453: 569-578.
23. El Maghraby GM, Arafa MF, Osman MA (2013) Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation. Drug Dev Ind Pharm.
24. Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RH, et al. (2007) Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm 67: 699-706. (Pubitemid 47576613)
25. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, et al. (2009) Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10: 69-76.
26. Heuschkel S, Goebel A, Neubert RH (2008) Microemulsions-modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci 97: 603-631. (Pubitemid 351293872)
27. Azeem A, Ahmad FJ, Khar RK, Talegaonkar S (2009) Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech 10: 1093-1103.
28. Tsai PJ, Huang CT, Lee CC, Li CL, Huang YB, et al. (2013) Isotretinoin oil-based capsule formulation optimization. ScientificWorldJournal 2013: 856967.
29. Makraduli L, Crcarevska MS, Geskovski N, Dodov MG, Goracinova K (2013) Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres. J Microencapsul 30: 81-92.
30. Pabari RM, Ramtoola Z (2012) Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. Int J Pharm 430: 18-25.
31. Kimura C, Nakanishi T, Tojo K (2007) Skin permeation of ketotifen applied from stick-type formulation. Eur J Pharm Biopharm 67: 420-424. (Pubitemid 47211906)
32. Aydogmus Z (2008) Highly sensitive and selective spectrophotometric and spectrofluorimetric methods for the determination of ropinirole hydrochloride in tablets. Spectrochim Acta A Mol Biomol Spectrosc 70: 69-78.
33. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, et al. (2007) Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 96: 2409-2423. (Pubitemid 47477896)
34. Osborne DW, Ward AJ, O'Neill KJ (1991) Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol 43: 450-454.
35. Piemi MP, Korner D, Benita S, MartyJp (1999) Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 58: 177-187. (Pubitemid 29112888)
36. Wu H, Ramachandran C, Weiner ND, Roessler BJ (2001) Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm 220: 63-75. (Pubitemid 32476842)
37. Raza K, Negi P, Takyar S, Shukla A, Amarji B, et al. (2011) Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul 28: 190-199.